Curtana Pharmaceuticals Company

Curtana is a biopharmaceutical company that has developed therapies for the treatment of the most aggressive types of brain cancer.

Investors

Technology: Small Molecules
Industry: Biopharma, Biotechnology, Pharmaceutical
Headquarters: Austin, Texas, United States
Founded Date: 2013
Employees Number: 1-10
Funding Status: Seed
Investors Number: 3
Total Funding: 52288
Estimated Revenue: Less than $1M
Last Funding Date: 2017
Last Funding Type: Grant

Visit Website
info@curtanapharma.com
Register and Claim Ownership